InforCapital

Healthtech Investors in Asia

12 investors found

Browse 12 Healthtech Investors in Asia. Discover top investors, their portfolios, AUM, and investment focus on InforCapital.

aMoon

aMoon

InvestorIsrael1.0B AUM

Founded in 2016 and headquartered in Ra’anana, Israel, aMoon is a leading venture capital firm dedicated to transforming healthcare through groundbreaking science and technology. The firm was established by visionary entrepreneurs—including Marius Nacht (co-founder of Check Point Software) and Dr. Yair Schindel—and immediately set out to back moonshot innovations across digital health, life sciences, and medtech. aMoon operates globally, with a strategic presence in key innovation hubs. With a multidisciplinary team exceeding 50 scientists, physicians, and investment specialists, aMoon invests across the full company lifecycle through its fund platforms: aMoon Velocity (early-stage), aMoon Growth (mid-to-late-stage), and public equity strategies. Their strength lies in bridging early-stage scientific breakthroughs with global commercialization pathways, backed by deep domain expertise and global networks. Over the years, aMoon has built a strong track record—having made over 70 investments across healthcare and biotech, including recent deals in 2025, and backed notable exits like DayTwo and Omada’s IPO. Assets under management are estimated at over $1 billion, with some sources placing it between $750 million and $1.3 billion.

Bosch Ventures

Bosch Ventures

InvestorChina200M AUM

Bosch Ventures, officially known as Robert Bosch Venture Capital GmbH (RBVC), is the corporate venture capital arm of the Bosch Group. Established in 2007, RBVC invests globally in innovative startups across all stages of development, focusing on technologies that are strategically significant to Bosch's future. RBVC's investment portfolio encompasses sectors such as automation, electrification, energy efficiency, enabling technologies, and healthcare systems. By leveraging Bosch's extensive global network and industry expertise, RBVC provides not only capital but also strategic support to its portfolio companies, fostering growth and innovation. With offices in Germany, the United States, Israel, and China, RBVC maintains a strong international presence. The firm typically invests between €500,000 and €10 million per company, with total assets under management exceeding €200 million.

Cathay Innovation

Cathay Innovation

InvestorChina2.8B AUM

Founded in 2015 by Mingpo Cai and Denis Barrier, Cathay Innovation is a global venture capital firm affiliated with Cathay Capital. The firm focuses on multi-stage investments in innovative startups across sectors such as artificial intelligence, fintech, digital health, consumer technology, and energy. With offices spanning North America, Europe, Asia, and Latin America, it leverages a global network to support founders in scaling their ventures internationally. In 2025, Cathay Innovation launched its largest fund to date—Fund III, a $1 billion investment vehicle focused on AI startups. The fund targets application-layer innovations in digital health, consumer apps, fintech, and energy/mobility. Strategic LPs include leading corporates such as Sanofi, TotalEnergies, and BNP Paribas Cardif, reinforcing the firm’s strong links between venture investment and corporate innovation. The firm invests from Series A to late-stage rounds with check sizes ranging from $5 million to $80 million. Already backing 14 companies through Fund III, including Nabla and Mogic AI, Cathay Innovation unites startups, investors, and corporates to deliver strategic growth. Its hybrid global-local model ensures unique market access and operational support to portfolio companies worldwide.

Grove Ventures

Grove Ventures

InvestorIsrael500M AUM

Grove Ventures is a Tel Aviv‑based early‑stage venture capital firm founded in 2016 by veteran entrepreneurs including Dov Moran (inventor of the USB flash drive), Lotan Levkowitz, and Lior Handelsman. With over $500 million under management, the fund backs Israeli founders building transformational technologies in sectors like AI, deeptech, digital health, semiconductors, and cloud infrastructure. The firm’s investment strategy focuses on Pre‑Seed, Seed, and Series A rounds, with typical checks between ~$500 K to $5 M. Grove emphasizes hands‑on support, helping portfolio companies scale via business development, talent, fundraising, and market access while investing in hard‑to‑replicate technical innovation. Grove Ventures’ portfolio includes standout startups such as Wiliot, RapidAPI, ActiveFence, Lumigo, Navina, Limitless CNC, Deepchecks, CommonGround, and OneLayer. The firm has backed around 60‑70 companies, achieving multiple successful exits and demonstrating sustained value‑creation for founders and investors alike.

Insight Partners

Insight Partners

InvestorHong Kong90.0B AUM

Insight Partners is a global growth‑stage investor that focuses exclusively on software and technology‑enabled businesses. Since its founding in 1995, the New York‑headquartered firm has deployed capital across more than 800 companies worldwide and guided over 55 of them to public offerings. With more than US$90 billion under management, Insight invests at every stage from minority growth rounds to majority buyouts, but always with an eye toward helping founders scale efficiently. The firm’s Onsite program provides portfolio companies with a dedicated team of operators, marketers, engineers and talent specialists who help drive product development, revenue growth, sales effectiveness and executive hiring. Insight’s portfolio spans vertical and horizontal software, cybersecurity, fintech, data analytics and digital infrastructure across North America, Europe, Israel and Asia. Unlike many investors, the firm is comfortable writing very large checks and often leads financing rounds. Insight prioritizes partnership, often remaining involved for years as companies expand into new markets or prepare for IPOs. Its culture blends analytical rigor with entrepreneurial empathy, rooted in the belief that enduring software companies are built through disciplined execution, customer obsession and continuous innovation.

Kakao Ventures

Kakao Ventures

InvestorSouth Korea325M AUM

Kakao Ventures (originally founded as K Cube Ventures in April 2012 and rebranded in March 2017) is a Seoul‑based early‑stage venture capital firm and an independent subsidiary of Kakao Corp. Although fully owned, its funds are operated with external LP capital, preserving a neutral, founder‑friendly investment mandate. Kakao Ventures manages approximately 430 billion KRW (~USD 300–325 million) in assets across eleven vintage funds, with planned expansion to 440 billion KRW. The firm has built a diversified portfolio of over 190 startups, focusing on high‑growth sectors including software, ICT services, deep tech, digital healthcare and gaming. Positioning itself as a "co‑pilot" to mission‑driven founders, Kakao Ventures invests from seed through early Series A stages, both within Korea and in global markets like the U.S., Japan, India, Germany and Southeast Asia. The team values entrepreneurs with clear purpose and domain expertise, offering hands‑on support and network engagement to fuel scalable growth.

Lightspeed Venture Partners

Lightspeed Venture Partners

InvestorChina28.2B AUM

Lightspeed Venture Partners is a global venture capital firm founded in 2000, specializing in multi-stage investments across enterprise, consumer, fintech, and healthcare sectors. With a mission to accelerate disruptive innovations, Lightspeed has backed over 500 companies worldwide, including notable names like Snap, Affirm, and Nutanix. The firm's collaborative approach and deep industry expertise have positioned it as a trusted partner for entrepreneurs aiming to build impactful businesses. Operating from 14 offices across the United States, Europe, Asia, and Israel, Lightspeed maintains a strong global presence. This extensive network enables the firm to identify and support promising startups in diverse markets. By providing not only capital but also strategic guidance, Lightspeed helps its portfolio companies navigate the challenges of scaling and innovation. As of 2025, Lightspeed manages approximately $28.2 billion in assets under management, reflecting its significant role in the venture capital landscape. The firm's commitment to fostering innovation and long-term partnerships continues to drive its success in supporting the next generation of industry leaders.

Mayfield Fund

Mayfield Fund

InvestorIndia3.0B AUM

Mayfield Fund, established in 1969 by Thomas J. Davis Jr., is a renowned venture capital firm based in Menlo Park, California. With over five decades of experience, Mayfield has been instrumental in supporting early-stage companies, focusing on sectors such as enterprise technology, consumer internet, and healthcare. The firm's commitment to a "People First" philosophy has guided its investment approach, emphasizing strong partnerships with visionary entrepreneurs. Operating globally, Mayfield manages approximately $3 billion in assets under management. The firm has invested in over 550 companies, leading to more than 120 IPOs and over 225 mergers or acquisitions. Mayfield's investment strategy includes seed, Series A, and select Series B rounds, providing not only capital but also strategic guidance to help startups navigate their growth trajectories. Mayfield maintains offices in Menlo Park, California, and Mumbai, India, enabling the firm to engage closely with entrepreneurs across North America and Asia. The firm's dedicated India fund, Mayfield India II, focuses on early-stage investments in technology companies within the region. With a team of approximately 74 employees, Mayfield continues to foster innovation and drive success for its portfolio companies worldwide.

Quadria Capital

Quadria Capital

InvestorIndia4.0B AUM

Founded in 2012, Quadria Capital is a Singapore-headquartered private equity firm specializing in the healthcare sector. With a strategic focus on South and Southeast Asia, Quadria aims to bridge the healthcare gap in these regions by investing in scalable and impactful healthcare businesses. The firm operates with a mission to deliver both strong financial returns and meaningful social impact. Quadria's investment portfolio spans various subsectors, including healthcare delivery, life sciences, medical technology, and associated healthcare services. By partnering with exceptional healthcare companies, Quadria provides growth capital and strategic support to enhance their operational capabilities and expand their reach. The firm's approach combines deep industry expertise with a commitment to environmental, social, and governance (ESG) principles. As of May 2025, Quadria Capital manages over US$4 billion in assets across 27 investments in countries such as India, Vietnam, Indonesia, Malaysia, and Singapore. The firm's recent closing of its third fund at US$1.07 billion underscores its position as a premier healthcare investor in Asia, dedicated to transforming healthcare systems and improving access to quality care in the region.

Redpoint Ventures

Redpoint Ventures

InvestorChina4.0B AUM

Redpoint Ventures, founded in 1999, is a renowned global venture capital firm headquartered in Menlo Park, California. With additional offices in San Francisco, Los Angeles, Beijing, and Shanghai, the firm partners with exceptional entrepreneurs to build market-leading companies that redefine the future of technology. The firm invests across seed, early, and growth stages in a wide array of sectors, including enterprise software, fintech, consumer internet, and digital health. Redpoint has backed over 465 companies, with standout investments in iconic names such as Netflix, Twilio, Snowflake, Stripe, and HashiCorp, demonstrating its track record of identifying and supporting high-potential ventures. With over $4 billion in assets under management, Redpoint provides not just capital but strategic guidance and access to a deep network of industry leaders. The firm is known for its long-term support and deep commitment to innovation and scalable growth across global markets.

Samsung Catalyst Fund

Samsung Catalyst Fund

InvestorIsrael300M AUM

Samsung Catalyst Fund is the evergreen, multi‑stage corporate venture capital arm of Samsung Electronics, headquartered in San Jose, California, with offices also in Seoul, Tel Aviv and Paris. Fully owned by Samsung Electronics, it operates with independent investment decision‑making authority and fiduciary responsibility to its portfolio companies while leveraging Samsung’s global scale and domain expertise. Founded in 2013, SCF targets startups across deep‑tech infrastructure and data‑enabled platforms, spanning sectors such as data center and cloud computing, artificial intelligence, networking & 5G, automotive, sensors, quantum computing, robotics, digital health, IoT, and semiconductors. SCF pursues multi‑stage investments—from Series A to late stage—and supports portfolio companies with capital, engineering mentorship, corporate development and access to Samsung’s global resources. The fund prioritizes not just financial return but co‑prosperity: success for SCF goes hand in hand with growth for entrepreneurs, partner investors, customers, and the wider community. Its investment portfolio includes firms like Axelera AI, Axiado, Celestial AI, DreamBig Semiconductor, Groq, Enfabrica, Skylo and Tenstorrent, among others. Recent investments were made into Skylo, Axiado, Tenstorrent, Enfabrica, DreamBig, Axelera AI, and Celestial AI.

SBI Investment

SBI Investment

InvestorJapan

SBI Investment Co., Ltd., founded in 1996 and headquartered in Tokyo, Japan, is a core venture capital company within the SBI Group. It operates and manages venture capital funds with a mission to become a "New Industry Creator," focusing on creating and cultivating core industries of the 21st century. As part of the SBI Group, which offers a broad range of online financial services including banking, securities, and insurance, SBI Investment supports the growth and business development of unlisted startups through strategic VC investments. The firm has invested in a total of 1,314 companies domestically and internationally, with 219 successful exits via IPOs or M&As as of March 31, 2025. Its investment philosophy emphasizes backing ventures in growth sectors such as information technology, biotechnology, and life sciences, while expanding into emerging fields like 5G, Internet of Things (IoT), big data, robotics, healthcare, infrastructure, and agriculture. SBI Investment leverages the SBI Group’s extensive management resources to help portfolio companies overcome operational challenges and enhance corporate value. Investment decisions at SBI Investment are guided by a comprehensive evaluation of management talent, market potential, uniqueness, competitive differentiation, and business model feasibility. An advisory board of specialists and fund investors ensures diversified and well-rounded investment judgments. With a commitment to supporting venture companies’ growth aspirations, SBI Investment contributes to societal advancement and the realization of innovative technologies aligned with Industry 4.0 and Society 5.0 goals.

You reached the end.

Introduction to Healthtech Investors in Asia

The burgeoning sector of healthtech in Asia has garnered significant attention from investors worldwide. This dynamic field, encompassing digital health, medical devices, biotechnology, and more, is bolstered by a growing demand for innovative healthcare solutions. Among the key players are healthtech investors operating within Asia, who play a pivotal role in driving advancements and scaling disruptive technologies across the region.

Investment Strategies and Focus

Understanding Healthtech Investor Strategies

Healthtech investors in Asia typically employ a strategic approach that involves a deep understanding of both technological advancements and healthcare needs. Their investment strategies often focus on early to late-stage companies that demonstrate the potential to transform healthcare delivery and improve patient outcomes. By targeting companies with scalable solutions and robust business models, these investors aim to maximize returns while driving meaningful impact in the healthcare sector.

Key Areas of Investment Focus

The investment focus of healthtech investors in Asia primarily revolves around sectors such as telemedicine, AI-driven diagnostics, personalized medicine, and health data management. By concentrating on these areas, investors seek to capitalize on the rapid technological advancements and the increasing adoption of digital health solutions in the region. This focus not only addresses pressing healthcare challenges but also aligns with global trends in health innovation.

Geographic Presence and Expansion

Healthtech investors in Asia are strategically positioned across major hubs such as China, India, Japan, and Southeast Asia. Their geographic presence allows them to leverage local expertise and networks while accessing a diverse range of investment opportunities. Additionally, many of these investors are expanding their reach beyond Asia, forging partnerships and establishing offices in other key markets to facilitate cross-border investments and collaborations.

Importance for LPs and Deal Professionals

Value to Limited Partners (LPs)

For Limited Partners (LPs) seeking exposure to the promising healthtech sector, investors in Asia offer a compelling proposition. These investors provide LPs with access to a rapidly growing market characterized by innovation and high growth potential. Furthermore, their expertise in navigating the unique challenges and opportunities within the Asian healthcare landscape enables LPs to make informed investment decisions that align with their strategic objectives.

Opportunities for Deal Professionals

Deal professionals looking to engage with healthtech investors in Asia can benefit from the wealth of opportunities available in this vibrant sector. Collaborating with these investors allows deal professionals to tap into a network of industry experts, gain insights into emerging trends, and identify potential investment targets. Moreover, the collaborative nature of the healthtech ecosystem in Asia fosters partnerships that can enhance deal flow and facilitate successful transactions.

Conclusion

The curated directory of healthtech investors in Asia provided by InforCapital serves as a valuable resource for those seeking to explore investment opportunities in this dynamic sector. With a strategic focus on transformative technologies and a strong presence across key markets, these investors play a crucial role in advancing healthcare innovation in Asia. For LPs and deal professionals alike, engaging with these investors can unlock significant value and drive success in the fast-evolving healthtech landscape.